Diagnostic Medical Systems (FR:ALDMS) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Diagnostic Medical Systems (DMS) Group has reported a 13% increase in revenue for the third quarter of 2024, reaching €10 million, driven by strong performance in its Radiology and Osteodensitometry segments. The company’s total revenue for the first nine months of 2024 grew by 11%, with significant contributions from international markets.
For further insights into FR:ALDMS stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money